TABLE 6.
SERIOUS ADVERSE EVENTS DURING THE MIRA-1 STUDY
| RELATION TO TREATMENT | TREATMENT DAY | TREATMENT PHASE | POST-TREATMENT |
|---|---|---|---|
| Possible | Atrial fibrillation (1) | ||
| Unlikely | Bigeminy (1)
Possible angina (1) |
Pneumonia (1) | Other (4) |
| Not Related | Other (19) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.